chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 12 hrs. after receiving the second dose, I suddenly felt very ill. Chills, dizzy, muscle and joint pain, and nausea. Fever up to 101. Symptoms worsened to the point, I couldn't move. Sharpest pain was in my upper back between my shoulder blades like the back of my chest. It hurt to breathe. Oxygen saturation dropped to 84-89 when I tried to move. Joint pain so bad that I couldn't pick up my cell phone with my hands. I alternated Tylenol and Ibuprofen. I started feeling better 48 hours after the second dose was administered.
Joint pain, chest pain, labored breathing.  Was admitted into hospital: troponin levels fluctuated, blood pressure was slightly elevated Echocardiogram & stress test was normal.  As of today, still having labored breathing.
This spontaneous report was received from a medical assistant referring to a 39 years old patient of unknown gender. Information about medical history, concurrent conditions and concomitant therapies was not provided. On 01-MAR-2019, the patient was inadvertently vaccinated with an expired dose of RECOMBIVAX HB lot# M046373 with expiration date was reported as 04-NOV-2018, intramuscular in the left deltoid (dose detail was not reported) for prophylaxis (expired vaccine used). No adverse effects were reported.
At 3 am I woke up feeling very cold.  Took my temp at 7 am and it was 99.  Had a slight headache and warm and cold off and on.  I took 1 Advil at 8 am and alternated every 4 hours with tylenol.  By 2 pm I felt fine and was able to go for a walk.
Patient reported fever (103 degree F) (which resolved within 2-3 hrs), chills, delirium the evening of receiving her shot. Symptoms resolved later that evening and patient felt fine next day.
Patient received the vaccine and proceeded to walk to the front of the store.  He describes the experience as his ears stopped hearing and he fell to his knees (passed out).  Patient did not report that he had been hurt in any way.  He came back to the pharmacy where we had him sit with his legs up.  He already had a bottle of water and was drinking.  Patient's blood pressure was a bit elevated 139/104.  He declined a second blood pressure check.  He stayed waiting for approximately 15 minutes then felt well enough to leave.
A 45 year old male patient experienced joint pain in his elbows, ankles and knees, increasing muscle pain, lateral abdominal pain, fever, sore neck, nasal congestion and stiff neck, while being treated with RabAvert. He received RabAvert on 07/15/04, 07/18/04 and 07/21/04 and was planning to get the next dose on 07/28/04. His medical history was significant for treatment with Rabies Immune Globulin (RIG) after receiving a cat bite in Thailand. He developed a rash post RIG treatment which was treated with Clarinex, Atarax and Prednisone. Concomitant medication included acetaminophen. On 07/26/04, 5 days past the 3rd dose of RabAvert the patient complained of fever and joint pain in his elbows, knees and ankles. The following day he complained of increasing muscle pain, lateral abdominal pain, sore neck, nasal congestion and stiff neck. The patient's fever was 99F in the doctor's office. He was referred to an infectious disease physician. Following up information received 08/19/04: Following a cat bite, the patient received 3 doses of Rabipur before returning to the US. In the US he received 2 does of RabAvert. After the fifth dose, the patient was informed that his antibody level was inadequate and a sixth dose would be required. The dates of Rabipur and RabAvert administrations were provided. All of the previously reported events were resolved within 2 days. The events pyrexia and nasal congestion were deleted as the patient denied having a fever or nasal congestion. Follow up information received 08/23/04: The date of onset for the reported events except for low antibody levels was corrected to 07/15/04.
significant increase in Rheumatoid Arthritis symptoms; extreme fatigue and exhaustion; feeling ill  These symptoms lasted 6 days
Case number PHEH2014US020312, is an initial spontaneous report from a nurse received on 07 Oct 2014. This report refers to a 10-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with FLUVIRIN (batch number: 1412901) intramuscularly into the left arm on an unknown date. On 29 Sep 2014, she developed two swollen nodes above her collarbone on left side (reaction). On 03 Oct 2014, she completely recovered from the event. Seriousness and causality was not reported.
Sore Arm; FATIGUE; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Sore Arm) and FATIGUE (FATIGUE) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced AXILLARY PAIN (Sore Arm) and FATIGUE (FATIGUE). The patient was treated with Tylenol at an unspecified dose and frequency.   At the time of the report, AXILLARY PAIN (Sore Arm) and FATIGUE (FATIGUE) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Pt recvd vax & 3 days later exp lt lower quad pain which resolved in 24 hrs;
Had contact dermatitis reaction. Rash fine and itching then rash became worse and ended with dry scaling skin. Mom took to doctor. Had same reaction to PPD test given 6-2-14.
Pt developed circular raised rash at site 20x34mm at time pt visit with scab in center.
VACCINE ADMINISTERED 6/18 EXPIRED 6/14. NO ADVERSE EFFECTS NOTED
Tuesday Night - Interior of right eye had multiple color blockage (size of thumbnail) in lower section of eye that blocked out what I was seeing with horizontal orientation.  Wednesday Morning - shape was reduced to 1/3 its previously stated size, vertical orientation, depending on what I was looking at the color changed, but still blocked out portions of what I looked at.  Wednesday Morning - shape was 1/4 the original size, vertical orientation, varied in colors, but still blocking images completely
This spontaneous report was received from a registered nurse regarding an unspecified number of patient of unknown demographics. There was no information about concurrent condition and historical medication. After 19-FEB-2016, the patient were vaccinated with 1 dose of improperly stored PROQUAD (Merck) lot # L030591, expiration date- 10-FEB-2017, lot no. L044055, expiration date- 02-MAY-2017 and lot # L008353, expiration date- 11-SEP-2016. No adverse event was reported. The outcome of the event was unknown. Temperature was 7.1 F, Time frame: 30 minutes, no previous temperature excursion, call was because of data logger and outcome was supported until labeled expiry. Additional information has been requested.
5 hours after my shot I developed a headache.  Followed by 3-4 hours or tremors and a high temperature over 100.  My temperature decreased to 98 by noon, the following day.
Flu shot administered 10/12/2014. Pt's representative stated that 10/14/14 pt had red place where shot was given and warm to touch. No fever. Red place on arm still present as of 10/17/14 when rep. reported adverse event to pharmacy.
I developed a cough about two weeks after the last vaccine and had difficulty breathing. I couldn't take a deep breath. I went in and I had bilateral pneumonia. Then I was given albuterol sulfate and I still need it from time to time and I've never had any type of asthma issues before. She sent me to get pulmonary function testing which came back okay but with moderate need for the inhaler. I also had some heart palpations and went to have EKG after I finished the antibiotics that I was prescribed. After that I had another CAT scan done of my chest and the pneumonia was clear. I still have a wheeze and it gets sometimes rather than all the times and I do have the inhaler on me. I don't breathe like I did before and feel like there is still something wrong so I'm going back to see her on the 14th.
Patient received a 1st dose of Bexsero vaccine on 06/06/2023 came back 07/072023 received Trumenba as 2nd dose. Vaccines are not interchangeable.
Exp severe localized pain @ inj site radiating up to shoulder & down to elbow;pain described as intense burning & 15min ; tenderness @ inj site; tired w/minor aches;T99.9;w/swelling & redness;h/a;knot;unable to sleep d/t pain; knot persists
Inflammatory swelling of right thigh muscle with fever to 102.5 that resolved after 48 hours. 1 cm diameter spherical mass in right thigh muscle remains 3 days following vaccination.
Unrelated to vaccine: He had community acquired pneumonia; sepsis and septic shock. Went by ambulance to ER and that evening they got him to ICU room. I think they were administering strong antibiotic. He was in the hospital three days. Came home on Jan 27th. We started hospice on Jan 29 and he passed on February 23rd.
Time vaccine administered is not documented. Noted symptoms 4 hours after he received vaccine and out of work for 4 days. Did not see MD. Headache & Fever
Next day developed swelling  and blister at injection site.  Blister popped Sunday evening with clear drainage and open wound smaller than dime size.  Mom reports the size of a peanut out of it's shell.   Recommended OTC antibiotic ointment and bandaid BID x 3 days then open to air.  Call with any signs of infection.   Mom denies any redness, fever, purulent drainage, or systemic signs.of illness.
Information has been received from a licensed visiting nurse concerning a 12 month old male patient who on 25-JAN-2007 was vaccinated with ProQuad (LOT# 655748/1094F). There was no concomitant medication. On 01-FEB-2007 the patient developed a fever of 103F. On 02-FEB-2007 the patient experienced tachycardia with a heart rate of 208, turned blue around the lips and hands, and had periods of no breathing ("aptic episodes"). Also, the nurse mentioned that the patient's oxygen levels on room temperature air was 97% at the doctors office on 02-FEB-2007. That evening, the patient was admitted to the hospital. He was ordered on oxygen and observation at the hospital. Subsequently, the patient's symptoms resolved and he was discharged on 04-FEB-2007. The events were considered to be immediately life-threatening and other important medical events. There was no product quality complaint involved. Additional information has been requested.
Severe headache-fever-dizziness. Doctor visit, bedrest, Toradol injection for headache-Hydrozodone for headache
On the 2nd day after 2nd Pfizer vaccination I experienced dizziness then fainted, with fatigue and nausea
Information has been received from a medical center concerning a 7 year old female who on 06-JUN-2000 was vaccinated with Varivax. On 14-MAR-2006 the patient experienced chickenpox. She was diagnosed on 15-MAR-2006. No additional information was provided. The patient's sibling (WAES 0604USA02514) had a similar experience after vaccination with Varivax. Additional information has been requested.
Doctors describe it as a possible immune response. Starting with loss of appetite and weight loss with diarrhea. Heart palpitations and chest pain. Elevated heart rate when standing diagnosed as postural orthostatic tachycardia. Ankle swelling and upper abdominal pain with bloating. Decreased circulation in hands and feet. Symptoms have progressed over a six week period and have not improved.
Difficulty breathing, wheezing.  Albuterol nebulizer 3 times over the course of next 12 hours.
Fever; Headache; Back pain; Joint pain at wrist; Received the second dose one month and 10 days after getting the first dose; This case was reported by a consumer via call center representative and described the occurrence of fever in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 22nd October 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 22nd October 2019, 10 hrs after receiving Shingrix, the patient experienced fever, headache, back pain, arthralgia and drug dose administration interval too short. On an unknown date, the outcome of the fever, headache, back pain, arthralgia and drug dose administration interval too short were unknown.   It was unknown if the reporter considered the fever, headache, back pain and arthralgia to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had received the second dose one month and 10 days after getting the first dose, which led to shortening of the schedule. The patient received 2nd dose of Shingrix, about 10 hours after vaccination, the patient experienced fever, headache, back ache, and joint pain at wrist and shortening of the schedule. The reporter consented to follow up. No further details were provided. This case is 1 of 2 cases, reported by same reporter for the patient (wife).
she got a case of shingles recently and pick up a prescription for Valacyclovir; Information has been received from a pharmacist referring to an 81 year old female patient. The patient's concurrent condition, medical history and concomitant therapy were not reported. In 2015 (reported as 2 years ago), the patient was vaccine with ZOSTAVAX (lot number, strength and dose were not reported) subcutaneously for shingles prevention. On 03-AUG-2017, the patient reported to a pharmacy that she got a case of shingles recently and pick up a prescription for valacyclovir (1gm, three times daily, for 3 additional days on 28-JUL-2017). Packet offered. Health care professional adamant about not receiving. Packet not faxed. Treatment had given for shingles. No lab diagnostics were performed. The outcome of shingles was reported as recovering. Action taken with ZOSTAVAX was not applicable. The relationship between the event and the vaccine was not provided.
Diarrhea began about 2 hours after inject as well as fever; Diarrhea began about 2 hours after inject as well as fever; BP had increased to 170s SBP and 120s DBP; Experienced a near syncopal episode; Dizzy/Light headed; Eyes were fluttering; Nausea; Vomiting; This is a spontaneous report from a contactable nurse (patient). A 25-year-old female patient received second dose of BNT162B2, via intramuscular in left arm on 29Jan2021 08:30 am at single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included PCOS. Concomitant medication included celecoxib (CELEXA [CELECOXIB]), buspirone hydrochloride (BUSPAR). The patient previously took keflex [cefalexin] and cipro [ciprofloxacin] and experienced Known allergies: Cipro and Keflex. Historical vaccine of BNT162B2 at 25 year on 08Jan2021 for covid-19 immunisation. The patient stated on 29Jan2021 10 minutes post vaccine at 08:45 am she became lightheaded and dizzy. It was reported that her eyes were fluttering and experienced a near syncopal episode. Further assessment showed that her BP had increased to 170s SBP and 120s DBP. Her baseline SBP was 1-teens and 1-tens. She also experienced nausea and vomiting at that time. She was taken to ER for cardiac monitoring and eval. BP returned to normal spontaneously. Diarrhea began about 2 hours after inject as well as fever. Highest fever noted was 102.3. Discharged home from ER. Symptoms has subsided 24hrs post vaccine. The patient underwent lab tests and procedures which included blood pressure measurement: increased to 170s sbp and 120s dbp on 29Jan2021, blood pressure measurement: normal on 2021, body temperature: 102.3 on 29Jan2021. The facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been not been tested for COVID-19. The adverse events resulted in emergency room. No treatment was received for the adverse events. The outcome of the events recovered on an unspecified date of 2021.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the compatible time association, the possible contribution of suspect vaccine BNT162B2 to the event blood pressure high cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Swelling on left side of collarbone. Thought it was swollen lymph node but it is a large sized area but not overly swollen but it is noticeable.; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 16:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 09:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 09May2021, the patient experienced swelling on left side of collarbone. Thought it was swollen lymph node but it was a large sized area but not overly swollen but it was noticeable. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event but the patient reported that if it does not go away within that week, will seek treatment for it. The clinical outcome of the event swelling on left side of collarbone, thought it was swollen lymph node but it was a large sized area but not overly swollen but it was noticeable was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning a female who in February 2009, was vaccinated with the third dose of GARDASIL. Subsequently, 3 weeks after the 3rd dose administration, the patient had a Pap test. The Pap test was positive for high risk HPV. No other information provided. The patient called office for medical attention. Additional information has been requested.
4 days after getting the Moderna #1 vaccine, my left armpit has swelled up and in pain. Swelling seems to be the lymph node, but it also moving down the side of my armpit and is painful.
she had low blood sugar; droppy eyes; dizziness was extreme; she could not get up; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (she had low blood sugar), LID SULCUS DEEPENED (droppy eyes) and DIZZINESS (dizziness was extreme; she could not get up) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE DECREASED (she had low blood sugar), LID SULCUS DEEPENED (droppy eyes) and DIZZINESS (dizziness was extreme; she could not get up). At the time of the report, BLOOD GLUCOSE DECREASED (she had low blood sugar), LID SULCUS DEEPENED (droppy eyes) and DIZZINESS (dizziness was extreme; she could not get up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
Pt. received two vaccinations around 3:10pm. He was fine immediately following the injections. He stood up to wait for his father to be vaccinated. After the father's first injection, patient fell back against the plastic cart of supplies and started to lose consciousness. I immediately grabbed him and helped him to the floor. His mother assisted me. I stuck my head out of the consultation room to yell for my team lead. By the time I turned back around, patient was sitting in a chair and fully aware and conscious. I grabbed a fan and started blowing cool air on him while my team lead grabbed some cool cloths. Those were placed at the back of his neck and on his forehead. He was very pale but stayed conscious. I gave him some orange juice and bottled water. After about 15 minutes, his color had returned and he left the room with the assistance of his father. He had reported never having passed out or fainting after a vaccine and he has no known drug allergies.
no adverse event; Incorrect product storage; This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.  On 05-MAR-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) dose/ frequency: 1,  lot # T015598, expiration date 02-NOV-2021, for prophylaxis (route were not reported).  The temperature involved was 16.5 degrees F for 4 hours. The previous temperature excursion was 14.5 degrees F for 2 hours and 45 minutes, 15.6 degrees F for 3 hours and 21 degrees F for 5 hours and 30 minutes. A data logger was involved. No adverse event.   This is one of multiples cases received from the same reporter.; Sender's Comments:  US-009507513-2104USA003483:Original Case : 2104USA003483 US-009507513-2104USA003885:Original Case : 2104USA003483 US-009507513-2104USA003880:Original Case : 2104USA003483 US-009507513-2104USA003881:Original Case : 2104USA003483 US-009507513-2104USA003882:Original Case : 2104USA003483 US-009507513-2104USA003883:Original Case : 2104USA003483 US-009507513-2104USA003884:Original Case : 2104USA003483 US-009507513-2104USA003877:Original Case : 2104USA003483 US-009507513-2104USA003876:Original Case : 2104USA003483 US-009507513-2104USA003879:Original Case : 2104USA003483
Normal Arm soreness for first 2 days. Then went away, about 10 days later, severe arm soreness (Worse than the first 2 days).  I have been unable to workout and lift heavy objects... Pain/Soreness still persists at this time 04/28/2021.... I talked to a doctor and they are advising I see an orthopedic doctor to look at my shoulder/deltoid area.